マウスの自発運動量と不安様行動におけるヒスタミン神経系の役割 by MOHSEN ATTAYEB SALEH
The role of histaminergic neurotransmission in
locomotor activity and anxiety-like behavior
in mice
著者 MOHSEN ATTAYEB SALEH
号 84
学位授与機関 Tohoku University
学位授与番号 医博第3315号
URL http://hdl.handle.net/10097/61261
（書式１２） 
  
氏 名 
    
Mohsen Attayeb S. 
学 位 の 種 類 博士（医学） 
学位授与年月日 平成 26 年 9 月 24 日 
学位授与の条件 学位規則第 4 条第 1 項 
研 究 科 専 攻 東北大学大学院医学系研究科（博士課程）医科学専攻 
学位論文題目 
 
The role of histaminergic neurotransmission  
in locomotor activity and anxiety-like behavior in mice 
(マウスの自発運動量と不安様行動におけるヒスタミン神経系
の役割) 
論文審査委員 主査 教授 谷内 一彦 
   教授 柳澤 輝行 教授 菅原 明 
論 文 内 容 要 旨 
Histaminergic neurons are located in the tuberomamillary nucleus and project to almost 
all brain regions. They are involved in sleep-wakefulness regulation in integration with 
other systems. H3R antagonists increase histamine release and modulate other 
neurotransmitters by affecting other neurons in the brain. The prototype H3R antagonist, 
thioperamide, increases locomotor activity and anxiety-like behaviors. However, the 
mechanism underlying these effects has not been fully elucidated. Similar to effects of H3R 
antagonists, sleep deprivation also activates histaminergic neurotransmission and affects 
other neurotransmitters. 
This thesis reports the new roles of histaminergic neurotransmission in mice and 
consists of two parts: (1) The H3R antagonist project: this reports the use of a newly 
developed H3R antagonist, JNJ-10181457 (JNJ), to determine the mechanism underlying 
the H3R-mediated change in locomotor activity and anxiety-like behaviors, to better 
understand brain functions and (2) The chronic sleep deprivation project: this reports the 
use of dietary histamine restriction to prevent activation of histaminergic 
neurotransmission, to understand the influence of such an activation on negative outcomes 
of chronic sleep deprivation. 
In The H3R antagonist project, Male wild-type C57BL/6 black mice were treated with 
JNJ, and then assessed for anxiety-like behaviors in the elevated zero-maze and open-field 
tests. Locomotor activity was measured in an open-field test after α-fluoromethyl histidine 
(FMH), an irreversible histidine decarboxylase inhibitor, was administered to deplete brain 
histamine. FMH ameliorated the effect of JNJ on locomotor activity. The effect of H3 
blockade on locomotor activity was also examined in H1 and H2 receptor gene knockout mice 
(H1RKO and H2RKO, respectively), results of which showed that H1RKO mice, but not 
H2RKO mice, were affected. Anxiety-like behaviors were examined after blocking H1R using 
diphenhydramine or H2R using zolantidine. Zolantidine abolished the effect of JNJ, while 
diphenhydramine did the same but to a lesser extent. Following the behavioral studies, we 
used high performance liquid chromatography (HPLC) to measure the effects of JNJ on 
brain levels of histamine, Nτ-methylhistamine (tMH), and other monoamines, 
demonstrating an increase in histamine turnover ratio but no change in the levels of the 
other monoamines. 
In The chronic sleep deprivation project, a forced locomotor method was used to induce 
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four weeks of partial sleep deprivation for 20 hours per day, while a low histamine diet was 
used to prevent activation of histaminergic neurotransmission. Forty C57/6J black mice 
were divided to four groups: normal sleep plus normal diet, normal sleep plus low-histamine 
diet, sleep-deprived plus normal diet, and sleep-deprived plus low-histamine diet. We 
examined the behavior of the mice weekly for three weeks using open-field, elevated 
zero-maze, and Y maze, and ran a light-dark chamber test on the 4th week. At the end of the 
experiment, we measured histamine turnover ratio using HPLC and the mRNA expression 
level of the histamine-producing enzyme histidine decarboxylase (HDC) using real-time 
polymerase chain reaction (RT-PCR). We found that mice in the sleep-deprived and 
histamine-restricted group showed increased anxiety-like behavior in the open-field, 
elevated zero-maze, and light-dark chamber tests. We also found that the activation of 
histaminergic neurotransmission was prevented by a low-histamine diet. 
In conclusion, histaminergic neurotransmission activation using H3R antagonist 
increased the locomotor activity via H2R dependent mechanism, and anxiety-like behaviors 
through activation of both H1R and H2R. Furthermore, histaminergic neurotransmission 
alleviates the negative impact of chronic sleep deprivation on anxiety-like behavior. 
 
 

